|Day's Range||3.30 - 3.30|
|52 Week Range||2.71 - 5.01|
|PE Ratio (TTM)||-1.64|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MELVILLE, N.Y., June 14, 2017-- BioRestorative Therapies, Inc., a life sciences company focused on stem cell-based therapies, today announced that Mark Weinreb, the Company’ s CEO, will present a Company ...
Categories: Yahoo FinanceGet free summary analysis BioRestorative Therapies, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of BioRestorative Therapies, Inc. – Invitae Corp. and Natera, Inc. (NVTA-US and NTRA-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.01 million, Net ... Read more (Read more...)
MELVILLE, N.Y., April 20, 2017-- BioRestorative Therapies, Inc., a life sciences company focused on stem cell-based therapies, today announced the Australia Patent Office, a division of IP Australia- an ...